Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Hua Yang

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Cancer Medicine|September 15, 2020
The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissuesYu-Yan Pang, Jian-Di Li, Li Gao, et al.
Molecular Therapy Oncolytics|July 5, 2022
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2DShanglin Li, Ruocong Zhao, Diwei Zheng, et al.
American Journal of Hematology|August 31, 2018
Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical studyMing-Hua Yang, Wu-Qing Wan, Jie-Si Luo, et al.
Annals of Hematology|October 15, 2025
Prognostic scoring model incorporating clinical characteristics for pediatric hemophagocytic lymphohistiocytosis: a multicenter retrospective studyShu-Yi Guo, Ru Tang, Shi-Lin Liu, et al.
Frontiers in Oncology|August 29, 2022
Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: A report from the South China Children's Leukemia GroupLu-Hong Xu, Xu Geng, Ning Liao, et al.
Blood Cancer Journal|December 5, 2023
Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL groupDan-Ping Huang, Liang-Chun Yang, Yi-Qiao Chen, et al.
Frontiers in Oncology|April 15, 2022
A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective StudyYun-Yan He, Xiao-Jing Wu, Dun-Hua Zhou, et al.
Therapeutic Advances in Hematology|January 9, 2025
Prognostic significance of MRD and its correlation with arsenic concentration in pediatric acute promyelocytic leukemia: a retrospective study by SCCLG-APL groupZhong Fan, Liang-Chun Yang, Yi-Qiao Chen, et al.
Cancer|December 17, 2025
Real-world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG[PLUS]-CML 2023Zhong Fan, Qi-Wen Chen, Xiu-Ya Huang, et al.
Pharmacoepidemiology and Drug Safety|June 9, 2026
Early Identification of Differentiation Syndrome During ATRA and Arsenic Therapy in Pediatric NHR-APL: Insights From a 14-Year Multicenter CohortZhong Fan, Liang-Chun Yang, Yi-Qiao Chen, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Cancer Medicine|September 15, 2020
The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissuesYu-Yan Pang, Jian-Di Li, Li Gao, et al.
Molecular Therapy Oncolytics|July 5, 2022
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2DShanglin Li, Ruocong Zhao, Diwei Zheng, et al.
American Journal of Hematology|August 31, 2018
Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical studyMing-Hua Yang, Wu-Qing Wan, Jie-Si Luo, et al.
Annals of Hematology|October 15, 2025
Prognostic scoring model incorporating clinical characteristics for pediatric hemophagocytic lymphohistiocytosis: a multicenter retrospective studyShu-Yi Guo, Ru Tang, Shi-Lin Liu, et al.
Frontiers in Oncology|August 29, 2022
Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: A report from the South China Children's Leukemia GroupLu-Hong Xu, Xu Geng, Ning Liao, et al.
Blood Cancer Journal|December 5, 2023
Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL groupDan-Ping Huang, Liang-Chun Yang, Yi-Qiao Chen, et al.
Frontiers in Oncology|April 15, 2022
A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective StudyYun-Yan He, Xiao-Jing Wu, Dun-Hua Zhou, et al.
Therapeutic Advances in Hematology|January 9, 2025
Prognostic significance of MRD and its correlation with arsenic concentration in pediatric acute promyelocytic leukemia: a retrospective study by SCCLG-APL groupZhong Fan, Liang-Chun Yang, Yi-Qiao Chen, et al.
Cancer|December 17, 2025
Real-world efficacy and adverse events of frontline nilotinib in pediatric chronic myeloid leukemia in chronic phase: A prospective multicenter study from SCCCG[PLUS]-CML 2023Zhong Fan, Qi-Wen Chen, Xiu-Ya Huang, et al.
Pharmacoepidemiology and Drug Safety|June 9, 2026
Early Identification of Differentiation Syndrome During ATRA and Arsenic Therapy in Pediatric NHR-APL: Insights From a 14-Year Multicenter CohortZhong Fan, Liang-Chun Yang, Yi-Qiao Chen, et al.
Pageof 15